Latin American Pharmaceutical and Medical Device Compliance Congress and Best Practices Forum
D. Jeffrey Campbell moderated and Sandra González spoke at the Latin American Pharmaceutical and Medical Device Compliance Congress and Best Practices Forum in Mexico City, Mexico on July 29-31, 2014. Jeff moderated and Sandra was a panelist speaking on How the US Sunshine Act and Global Transparency Trends will Impact Latin America, on Wednesday, July 30. Additionally, Jeff moderated and Sandra was a panelist speaking on Advanced Issues In Global Transparency, Disclosure and Aggregate Spend Compliance, Mini Summit IX.
How the US Sunshine Act and Global Transparency Trends will Impact Latin America Discussion Points:
- Key Trends in Global Transparency
- Extraterritorial Impact of US and European Requirements on Latin American Operations
- Managing Data Privacy and Physician Consent
- Potential Developments in Latin America
Advanced Issues In Global Transparency, Disclosure and Aggregate Spend Compliance Discussion Points:
- Nuanced Definitions of Covered Recipients and Organizations
- Reporting Research and Development Payments
- Cross-border Spend
- Master Data Management
- Managing Vendor Agreements and Agreements with Covered Recipients
The 2nd Latin American Pharmaceutical and Medical Device Compliance Congress offered a rare opportunity for pharmaceutical and medical device companies conducting business in Latin America to hear from industry experts on cutting edge practical approaches to help manage these challenges in this fast growing region. The Congress is sponsored by the Latin American Ethics and Compliance Network, a voluntary group of pharmaceutical and medical device compliance professionals and legal counsel with regional oversight or responsibility across the Latin American region and co-sponsored by a number of organizations listed here on the right.
The Congress offered opportunities to hear from business leaders from the Industry, to identify top trends in this sector from Medical and Patient Organizations, to benchmark best practices from multi-national pharmaceutical and medical device corporations, to hear from several Latin American Pharma associations and learn about the latest codes and laws.
For more information, please click here